세계 헬스케어 컨설팅 서비스 시장 - 규모, 점유율, 동향 분석 보고서 : 서비스별, 최종 용도별, 지역별 부문 예측(2024-2030년)

Healthcare Consulting Services Market Size, Share & Trends Analysis Report By Services (Strategic Management Consulting, Financial Management Consulting), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,221,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,602,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,366,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

헬스케어 컨설팅 서비스 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 전 세계 헬스케어 컨설팅 서비스 시장 규모는 2030년까지 519억 8,000만 달러에 이르렀으며, 2024년부터 2030년까지 연평균 복합 성장률(CAGR)은 9.33%를 나타낼 것으로 예상됩니다.

생명과학기업과 정부기관 등 의료기관에서는 예산 삭감 증가, 업무 효율성 향상 요구, 의료 정책 및 규제 변화, 빅데이터 분석, 클라우드 배포, IoT 등 신기술 도입에 대한 수요 증가 등이 헬스케어 컨설팅 서비스 시장을 견인하는 주요 요인이 되고 있습니다.

헬스케어 컨설팅 서비스 기업은 의료기관의 효율과 이익 향상을 지원하고 기업에 대한 구조적인 제안도 실시합니다. 의료 컨설팅과 관련된 이러한 장점은 예측 기간 동안 이러한 서비스에 대한 수요를 향상시킬 것으로 예상됩니다. 수년에 걸쳐 의료 개혁을 둘러싼 불확실성, 고용자의 자기 보험 증가, 환자의 자기 부담 증가, 의료 보험 이해에 대한 수요가 증가했습니다. 이러한 문제는 지불자의 요구를 관리하는 헬스케어 컨설팅 서비스에 대한 수요를 향상시키는 것으로 보입니다.

제약회사는 신약의 연구개발에 상당한 투자를 하고 있습니다. 그 결과, 파이프라인에 있는 신약의 수는 최근 증가하고 있습니다. Pharma R&D annual review에 따르면 2022년 현재 20,109개 이상의 의약품이 파이프라인에 있습니다. 이러한 의약품은 향후 수년간 상시될 전망입니다. COVID-19 팬데믹으로 인한 불확실성으로 인해 제약 회사는 전략 컨설턴트와 협력하여 상시 전략을 수립할 것으로 예상됩니다. 이것은 유행 후 시장 성장을 지원할 것으로 예상됩니다.

헬스케어 컨설팅 서비스 시장 보고서 하이라이트

• 전략경영 컨설팅 분야는 2023년 세계 매출의 42.39%를 차지합니다. 제약회사, 바이오테크놀러지 기업 등 헬스케어 관련 기업 간의 합병·인수 증가가 전략적 경영 컨설팅 서비스 수요를 지원하는 주요 요인 중 하나가 되고 있습니다.
• 2023년에는 제약회사 및 생명공학 기업 부문이 시장을 독점했으며 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다.
• 북미가 시장을 독점했고 2023년에는 38.14%의 점유율을 차지했습니다. 이는 공개 회사, 제약 회사, 생명 공학 회사의 병원 및 기타 기관과 같은 의료 조직의 디지털 솔루션 채택이 증가했기 때문일 수 있습니다.
• 아시아태평양은 이 시장에서 가장 빠른 성장을 이룰 것으로 예상됩니다. 아시아태평양의 의료기관에 의한 지역적인 사업 확대 증가와 다수의 컨설턴트의 존재가 아시아태평양 시장 성장을 지지하는 주요 요인이 되고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 헬스케어 컨설팅 서비스 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 의료 컨설팅 서비스 시장 분석 도구
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석
  • 가격 분석

제4장 헬스케어 컨설팅 서비스 시장 : 서비스의 추정 및 동향 분석

• 서비스 시장 점유율, 2023년과 2030년
• 부문 대시보드
• 서비스별 세계의 헬스케어 컨설팅 서비스 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년

제5장 헬스케어 컨설팅 서비스 시장 : 최종 용도 추정 및 동향 분석

• 최종 용도 시장 점유율, 2023년 및 2030년
• 부문 대시보드
• 최종 용도별 세계의 헬스케어 컨설팅 서비스 시장 전망
• 시장 규모, 예측 및 동향 분석, 2018-2030년

제6장 헬스케어 컨설팅 서비스 시장 : 지역별 추정 및 동향 분석

• 지역 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 세계 지역 시장 현황
• 시장 규모와 예측 트렌드 분석, 2018-2030년:
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
• 회사/경쟁의 분류
• 벤더 상황
  • List of key distributors and channel partners
  • Key customers
  • Key company market share analysis, 2023
  • Accenture
  • McKinsey & Company
  • Deloitte Global
  • LEK Consulting
  • PwC
  • Huron Consulting Group Inc. and affiliates.
  • Cognizant
  • EY
  • Bain & Company, Inc.
  • IQVIA Inc,
  • Boston Consulting Group

JHS

영문 목차

영문목차

Healthcare Consulting Services Market Growth & Trends:

The global healthcare consulting services market size is expected to reach USD 51.98 billion by 2030 and register a CAGR of 9.33% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing budget cuts, the desire to enhance operational efficiency, changing healthcare policies and regulations, and growing demand to implement new technologies such as big data analytics, cloud deployment, and IoT among healthcare institutions such as life sciences companies and government bodies are some of the key factors driving the healthcare consulting services market.

Healthcare consulting services firms assist healthcare organizations in increasing their efficiency and profits; they also assist in providing structural recommendations for the firm. These advantages associated with healthcare consulting are expected to improve demand for these services across the forecast period. Over the years, there has been uncertainty over healthcare reform, growth in employer self-insurance, a rise in patient pay responsibility, and a growing demand for understanding healthcare coverage. These issues are likely to improve the demand for healthcare consulting services for managing payers' needs.

Pharmaceutical companies are heavily investing in the research and development of new drugs. As a result, the number of new drugs in the pipeline has increased in recent years. According to the Pharma R&D annual review, as of 2022, over 20,109 drugs were in the pipeline. These drugs are expected to be launched in the coming years. Due to the uncertainties created by the COVID-19 pandemic, pharmaceutical companies are expected to collaborate with strategic consultants to develop their launch strategy. This is expected to support market growth in the post-pandemic period.

Healthcare Consulting Services Market Report Highlights:

• The strategic management consulting segment accounted for 42.39% of the global revenue in 2023. The growing number of mergers and acquisitions among healthcare organizations such as pharmaceutical companies, biotechnology companies, and others is one of the major factors supporting the demand for strategic management consulting services.
• The pharmaceutical and biotechnology companies segment dominated the market in 2023 and it is also expected to witness the fastest growth over the forecast period.
• North America dominated the market and accounted for a 38.14% share in 2023. This can be attributed to the increased adoption of digital solutions by healthcare organizations such as public agencies, pharmaceutical companies, biotechnology companies' hospitals, and other institutions.
• Asia Pacific is anticipated to witness the fastest growth in the market. Increasing regional expansions in business by the health care organizations across region and the presence of a significant number of consultants are some key factors supporting market growth in Asia-Pacific.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Services
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Services outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Consulting Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing pressure to reduce costs in the healthcare settings.
    • 3.2.1.2. Increasing demand for digitalization
    • 3.2.1.3. Changing regulatory framework contributing to the demand for consulting services
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Intellectual Property Issues
• 3.3. Healthcare Consulting Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. Pricing Analysis

Chapter 4. Healthcare Consulting Services Market: Services Estimates & Trend Analysis

• 4.1. Services Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Healthcare Consulting Services Market by Services Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Strategic Management Consulting
    • 4.4.1.1. Strategic Management Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Financial Management Consulting
    • 4.4.2.1. Financial Management Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Information Technology Consulting
    • 4.4.3.1. Information Technology Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Human Resource Consulting
    • 4.4.4.1. Human Resource Consulting Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Healthcare Consulting Services Market: End-use Estimates & Trend Analysis

• 5.1. End-use Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Healthcare Consulting Services Market by End-use Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Pharmaceutical and Biotechnology Companies
    • 5.4.1.1. Pharmaceutical and Biotechnology Companies Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Hospitals
    • 5.4.2.1. Hospitals Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Healthcare Payers
    • 5.4.3.1. Healthcare Payers Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Other Healthcare Providers
    • 5.4.4.1. Other Healthcare Providers Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Healthcare Consulting Services Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2023 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Norway
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Sweden
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Denmark
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Mexico
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2023
  • 7.3.4. Accenture
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Services benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. McKinsey & Company
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Services benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Deloitte Global
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Services benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. L.E.K. Consulting
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Services benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. PwC
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Services benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Huron Consulting Group Inc. and affiliates.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Services benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Cognizant
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Services benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. EY
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Services benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Bain & Company, Inc.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Services benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. IQVIA Inc,
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Services benchmarking
    • 7.3.13.4. Strategic initiatives
  • 7.3.14. Boston Consulting Group
    • 7.3.14.1. Company overview
    • 7.3.14.2. Financial performance
    • 7.3.14.3. Services benchmarking
    • 7.3.14.4. Strategic initiatives

관련자료